About intravenous vaccine therapy for brucellosis

Abstract

When developing rational methods for treating brucellosis, a number of extreme difficulties are encountered. These include the uniqueness of the infection itself, the exceptional persistence of the pathogen, its ability to remain in a state of latency in the human body for a long time and, finally, its specific tendency to cause periodic exacerbations and relapses. An equally significant circumstance that complicates the assessment of this or that type of therapy is the lack of certain objective tests, taking into account which would help to accurately focus on some of the preferential and most effective methods in terms of their results.